Background. It has been suggested that left ventricular unloading at the time of reperfusion provides superior infarct salvage over reperfusion alone. The purpose of this study was to show that the Hemopump transvalvular axial-flow left ventricular assist device provides superior left ventricular unloading, ischemic zone collateral blood flow, and infarct size reduction compared with intra-aortic balloon counterpulsation and reperfusion alone.
Background. It has been suggested that left ventricular unloading at the time of reperfusion provides superior infarct salvage over reperfusion alone. The purpose of this study was to show that the Hemopump transvalvular axial-flow left ventricular assist device provides superior left ventricular unloading, ischemic zone collateral blood flow, and infarct size reduction compared with intra-aortic balloon counterpulsation and reperfusion alone.
Methods and Results. Eighteen dogs were instrumented with regional myocardial function sonomicrometers in the ischemic and control zones. The left anterior descending coronary artery just distal to the first diagonal branch was instrumented with a silk snare and Doppler flow probe. Additionally, pressure catheters were placed in the left atrial appendage, left ventricular apex, and ascending aorta for hemodynamic measurements. Regional myocardial blood flow was determined by using 15 -gm radioactive microspheres. Measurements were made in the control state, immediately after coronary occlusion, at 1 and 2 hours after coronary occlusion, with reperfusion, and 1 hour after reperfusion. In treated animals, left ventricular assistance was maintained during the entire period of occlusion and reperfusion. The Hemopump was associated with a significant decrease in left ventricular systolic and diastolic pressure, whereas mean arterial pressure was maintained. Intra-aortic balloon counterpulsation resulted in no significant changes in left ventricular systolic pressure and a modest decrease in left ventricular diastolic pressure. Regional unloading as assessed by sonomicrometers was significant in the Hemopump animals and absent in the balloon pump animals. Absolute regional myocardial blood flow in the ischemic zone increased slightly (p=0.002) in the Hemopump animals and did not change in the balloon pump animals. Infarct size expressed as percentage of the zone at risk was 62.6% in the control animals, 27.22% in the balloon pump T he concept of salvage of ischemic myocardial tissue by reperfusion therapy has been suggested by animal1 and human2 studies. Some investigators have reported that the level of collateral flow to the bed at risk determines ultimate infarct size3; others have suggested that the amount of collateral flow and degree of functional recovery are not correlated. 4 An additional possible benefit of reperfusion therapy is the concept that late reperfusion may not salvage left ventricular (LV) tissue or function but may limit infarct expansion.5 Additionally, reperfusion may induce further myocardial damage; however, there is no clear consensus regarding the extent or possible modification of this problem.6 Recent interest has focused on the actions of free radicals and use of free radical scavengers at the time of reperfusion. Unfortunately, at the present time, these studies have yielded conflicting results possibly because of differences in models and agents used. 7, 8 With the development of interventional techniques for salvaging ischemic myocardium, mechanical support of the ischemic left ventricle is another possible therapeutic modality. Some investigators have reported modest improvement in ischemic bed collateral flow by using intraaortic balloon counterpulsation.9 Others have suggested there is minimal LV unloading or increase in ischemic zone collateral flow with balloon counterpulsation. 10 An extremely aggressive approach that uses total cardiopulmonary bypass, LV venting, and cardioplegia before reperfusion has demonstrated a decrease in infarct size to 12% compared with 44% of the region at risk by using reperfusion alone.1" This technique would be impractical for widespread application.
A small, axial-flow, transvalvular LV assist device (the Hemopump Cardiac Assist System, Johnson and Johnson Interventional Systems Co.) has been developed that is capable of significant LV unloading and circulatory support and is considerably less invasive than total cardiopulmonary bypass. 12 We have previously demonstrated that this device improved collateral blood flow to ischemic tissue and reduced regional work. 13 The purpose of this study was to show that the Hemopump provides superior LV unloading, improvement in ischemic zone collateral flow, and infarct size reduction compared with intra-aortic balloon counterpulsation and reperfusion alone.
Methods

Animal Instrumentation
Eighteen mongrel dogs of either sex weighing 25-33 kg were anesthetized intravenously with 30 mg/kg pentobarbital and maintained with Inovar-Vet (20 mg droperidol and 0.4 mg fentanyl/ml). The 
Control Measurements
After instrumentation and stabilization, baseline sure, LV pressure, and regional end-diastolic segment lengths and segmental shortening in the circumflex and LAD regions were recorded. Three to 5 million 15 -jum radioactive microspheres (NEN-TRAC, DuPont) were injected in a volume of 1 ml through the left atrial catheter over 30 seconds, followed by 10 ml of normal saline. During the microsphere injection, arterial blood was continuously withdrawn from the ascending aorta for a period of 2 minutes with the use of a Harvard pump. After baseline control measurements, LV assistance was initiated in the Hemopump animals and the intra-aortic balloon animals. In the Hemopump animals, maximum flow was used (3.0-3.5 1/min, depending on mean arterial pressure and LV filling pressure). With the intra-aortic balloon pump, maximum augmentation was used provided that femoral artery pressure was not adversely affected. If it was evident that the intra-aortic balloon pump was occluding the aorta, the degree of augmentation was then reduced slightly from 40 ml to approximately 35 ml per beat. The above hemodynamic and microsphere measurements were repeated during LV assistance with the Hemopump or the balloon pump. After baseline measurements were obtained, the snare was tightened around the LAD to occlude it. Doppler flow measurements confirmed the occlusion of the LAD distal to the first diagonal. The ECG and rhythm were monitored with premature ventricular contractions being treated with intravenous lidocaine. Five minutes after LAD occlusion, hemodynamic and microsphere measurements were repeated on and off pump support.
After 2 hours of LAD occlusion, repeat hemodynamic measurements were obtained with and without LV assistance. The LAD snare was then released, and reperfusion was confirmed by Doppler flow measurements. Hemodynamic measurements were then repeated both with and without the LV assistance. LV assistance was continued for an additional 1-hour period of reperfusion in the Hemopump and intra-aortic balloon pump dogs. After 1 hour of reperfusion, measurements were repeated on and off assistance. Subsequent to the final hemodynamic measurements, the animals were killed with an injection of supersaturated potassium chloride. The hearts were immediately excised, rinsed in cold tap water, and trimmed of excess fat. The left ventricle was isolated, weighed, and sliced from base to apex in five to six 1-cm-thick sections. Each slice was then weighed and placed in freshly prepared 1% solution of triphenyltetrazolium chloride (TTC) and incubated for 45 minutes at 37°C to delineate viable and infarcted myocardium.14 Stained slices were then photographed for subsequent planimetry to determine infarct size. Microsphere flow measurements were obtained by dividing each slice into 1-g pieces that were identified and mapped on the photograph, thereby creating a flow map of each slice in 1-g subsections. The samples were analyzed according to the method of Heymann.15 The ischemic zone was determined to be that portion of the myocardium receiving less than 25% of blood flow delivered to the control (circumflex) the mass of tissue receiving low flow (region at risk). The infarct size fraction was determined by planimetering the area of the TTC-negative-stained tissue in each slice and dividing by the total area of the slice. The infarct area fraction was multiplied by the weight of each slice and summed slice-by-slice to determine the mass of infarcted tissue. The infarct mass was then divided by the region-at-risk mass to determine the infarct size as a percentage of the region at risk.
Statistical Analysis
A sample size of six animals per group was chosen to detect large (50%) changes between the groups in perfusion to the ischemic zone, infarct size, and hemodynamic parameters. One animal was excluded from the analysis in the balloon pump group because of the presence of high collateral blood flow (>0.3 ml/g/min) to the ischemic zone during the control occlusion. The experiments were not done in a preconceived random fashion; however, there was considerable mixing of the groups studied so that each group was not studied consecutively.
All data were expressed as mean±SD and analyzed by using the paired (when applicable) or unpaired Student's t test. Statistical significance was assigned a probability value of less than 0.05.
Results
Representative tracings from one of the Hemopump animals are shown in Figures IA and 1B . In the control state, institution of Hemopump LV assistance produced a diminution of LV systolic and diastolic pressure and a reduction in LAD as well as circumflex regional segmental end-diastolic dimension. During severe LAD ischemia, holosystolic paradoxical motion in the region of the LAD was uniformly demonstrated. LV enddiastolic pressure also increased in the majority of animals. With Hemopump LV support, however, LV segmental end-diastolic dimensions decreased, and there was minimal systolic paradoxical motion in the LAD region. Simultaneously, LV systolic pressure was markedly decreased and mean aortic pressure was maintained. As demonstrated by Figure 1B , at the end of a 2-hour LAD occlusion (during Hemopump support) the left ventricle ceased to eject, which provided a positive pressure gradient across the coronary collateral bed throughout the cardiac cycle. In Table 2 , the effect of the intra-aortic balloon pump on hemodynamics during LAD ischemia is shown. Similar to the Hemopump, the balloon pump produced little change in heart rate throughout the period of the experiment. Mean arterial pressure was not significantly changed by the balloon pump; however, there was a trend toward modest systolic LV pressure reduction. Generally, LV diastolic pressure did not appear to be affected by intra-aortic balloon counterpulsation except at 1 hour after reperfusion, when there was a slight but significant decrease in diastolic pressure. expressed as a ratio of ischemic zone blood flow to nonischemic zone blood flow in Table 5 . In each group in the control state, in the absence of ischemia, this ratio was 1, as anticipated. Similarly, with the onset of ischemia, the ratio dropped to approximately 10% of control flow as typically seen with severe ischemia in the dog model. However, in the Hemopump animals, the blood flow ratio improved significantly despite the fact that absolute blood flow to the risk region remained at depressed levels (0.10 ml/g/min).
Effect of Left Ventricular Assistance on Infarct Size
A summary of infarct size data in control, balloon pump, and Hemopump animals is shown in Table 6 . In general, the heart weights were similar, as were the risk regions, with a trend toward increased risk region in the Hemopump animals. The infarct size expressed as percentage of the region at risk in control animals was 62.6+15%. With intra-aortic balloon counterpulsation, this was reduced to 27% (p=0.01). With Hemopump support, the infarct size was further reduced to 21.7% (p=0.001). Although there was a trend toward smaller infarct size in the Hemopump dogs compared with the balloon pump dogs, this did not achieve statistical significance. Group data are depicted in Figure 3 . Discussion For the past decade, attempts at infarct salvage in acute myocardial infarction in humans have focused on the optimal methods of achieving reperfusion as well as prevention of reocclusion. During this period of time, many investigators have looked more closely at animal models for means of augmenting salvage of ischemic myocardium as well as prevention of reperfusion injury. An extensive review recently published by Opie6 discussed the roles of leukocyte plugging, free radical liberation by leukocytes and their deleterious effect on the endothelium, ultrastructure, and metabolism. In 
Implications for Further Studies
The mechanical interventions described in this study were initiated at the time of onset of ischemia. Clearly, this was not a clinically relevant study, given the fact that most patients presenting with severe ischemia or infarction are well into their course by the time they seek medical therapy. The maximum benefit of mechanical LV unloading might in fact occur not only during reperfusion but in the subsequent several days after reperfusion during the period of infarct remodeling. Lower wall stress associated with significant LV unloading during this remodeling phase may well result in a smaller ultimate LV size, in addition to improved function. Whether LV unloading initiated just before reperfusion results in infarct salvage remains unclear at the present time.
Potential difficulties are the risk of leg ischemia associated with both intra-aortic balloon counterpulsation and the insertion of other LV devices, including the Hemopump, via the leg vessels. The Hemopump currently requires the use of a 12-mm woven Dacron graft for insertion similar to the early models of intra-aortic balloon devices. Because femoral artery cutdown (especially in the setting of thrombolysis) is a major source of potential complications, further animal studies are warranted prior to widespread human trials in acute myocardial infarction. Nonetheless, we are encouraged by these results and anticipate that wedding mechanical LV unloading with further pharmacological intervention at the time of reperfusion may prove to be synergistic.
